The competitive landscape of drug eluting balloon industry
2024-06-11
Coronary drug eluting balloon is a high-end third class medical device, the product has high precision technology, high entry barriers. The development of China's drug balloon industry started late, the development time is short, the domestic market is dominated by several companies, and there is still a large room for progress. Up to now, there are 10 coronary drug-eluting balloon products in China, and the main indication is intrastent restenosis. One of the earliest to market is the German Bayern SeQuent Please, which is indicated for the treatment of coronary artery restenosis in the stent. In 2017, Yinyi's Light boat ® drug-eluting balloon was approved by the former State Food and Drug Administration (CFDA), which is the first product suitable for primary coronary bifurcation disease in the world, and the first product in China to obtain registration certificate.
With the gradual development of clinical application research, participants successively obtained registration certificates of coronary drug balloon products, such as Shanghai Shenqi, Lepu Medical, Kaidenuo (Broad Medical), Winson Medical, Batai Medical, Dingke Medical. In the future, with more competitors and competitive products entering the market, market competition will intensify, but the entry of competitive products will further strengthen the domestic market education of the industry and promote the increase of product market penetration. Among them, the Light boat ® drug eluting balloon of Yinyi Biology has excellent passability and delivery, excellent drug coating quality, and has been clinically applied in a number of well-known cardiovascular hospitals and more than 1,000 hospitals in China, and its sales growth has been rapid after launch, breaking the market monopoly of Bayron in Germany. In recent years, the implementation of the collection policy has accelerated the growth of market demand, and the sales volume of light boat ® drug eluting balloons has increased rapidly. According to Frost & Sullivan data, its sales volume in 2021 ranks first in the domestic market, accounting for 41.5% of sales, exceeding the 27.1% of Germany Bellan.
Previous
Previous
Related recommend